Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Sansom

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biochemical Society Transactions|August 1, 1996
Mutagenesis and modeling of endothelin converting enzymeV M Hoang, C E Sansom, A J Turner
Molecular Membrane Biology|October 1, 1995
Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamilyM F Varela, C E Sansom, J K Griffith
Trends in Biochemical Sciences|December 1, 1995
The first prokaryotic lipocalinsD R Flower, C E Sansom, M E Beck, et al.
Anti-Cancer Drug Design|February 1, 1990
Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNAA S Clark, M F Stevens, C E Sansom, et al.
Biochemical Society Transactions|October 1, 1990
Active-site modelling of class I beta-lactamasesC A Toomer, P A Lambert, C E Sansom, et al.
Molecular Microbiology|February 1, 1995
Topological analyses of the L-fucose-H+ symport protein, FucP, from Escherichia coliF J Gunn, C G Tate, C E Sansom, et al.
Anti-Cancer Drug Design|August 1, 1990
Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNAC E Sansom, C A Laughton, S Neidle, et al.
Journal of Medicinal Chemistry|September 4, 1992
Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTICP R Lowe, C E Sansom, C H Schwalbe, et al.
Biochimica Et Biophysica Acta|March 16, 1989
Structural studies on bio-active compounds. Part XV. Structure-activity relationships for pyrimethamine and a series of diaminopyrimidine analogues versus bacterial dihydrofolate reductaseC E Sansom, C H Schwalbe, P A Lambert, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biochemical Society Transactions|August 1, 1996
Mutagenesis and modeling of endothelin converting enzymeV M Hoang, C E Sansom, A J Turner
Molecular Membrane Biology|October 1, 1995
Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamilyM F Varela, C E Sansom, J K Griffith
Trends in Biochemical Sciences|December 1, 1995
The first prokaryotic lipocalinsD R Flower, C E Sansom, M E Beck, et al.
Anti-Cancer Drug Design|February 1, 1990
Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNAA S Clark, M F Stevens, C E Sansom, et al.
Biochemical Society Transactions|October 1, 1990
Active-site modelling of class I beta-lactamasesC A Toomer, P A Lambert, C E Sansom, et al.
Molecular Microbiology|February 1, 1995
Topological analyses of the L-fucose-H+ symport protein, FucP, from Escherichia coliF J Gunn, C G Tate, C E Sansom, et al.
Anti-Cancer Drug Design|August 1, 1990
Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNAC E Sansom, C A Laughton, S Neidle, et al.
Journal of Medicinal Chemistry|September 4, 1992
Antitumor imidazotetrazines. 25. Crystal structure of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) and structural comparisons with the related drugs mitozolomide and DTICP R Lowe, C E Sansom, C H Schwalbe, et al.
Biochimica Et Biophysica Acta|March 16, 1989
Structural studies on bio-active compounds. Part XV. Structure-activity relationships for pyrimethamine and a series of diaminopyrimidine analogues versus bacterial dihydrofolate reductaseC E Sansom, C H Schwalbe, P A Lambert, et al.
Pageof 2